Incidence and risk factors for psoriasis in the general population

被引:249
作者
Huerta, Consuelo [1 ]
Rivero, Elena [2 ]
Rodriguez, Luis A. Garcia [1 ]
机构
[1] Spain Ctr Pharmacoepidemiol Res CEIFE, Madrid 28004, Spain
[2] Novartis Farmaceut SA, Dept Clin Epidemiol, Barcelona, Spain
关键词
D O I
10.1001/archderm.143.12.1559
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objectives: To study the clinical spectrum of psoriasis and the incidence in the general population and to identify risk factors associated with the occurrence of psoriasis. Design: Prospective cohort study with nested case-control analysis. Setting: The data source was the United Kingdom General Practice Research Database containing computerized clinical information entered by general practitioners (GPs). Patients: The study population comprised patients receiving a first-ever diagnosis of psoriasis between January 1, 1996, and December 31, 1997, and free of cancer. Interventions: Diagnosis of psoriasis was validated in a random sample of 14% of all ascertained cases requesting confirmation by the GPs. Nested case-control analysis included 3994 cases of psoriasis and a random sample of 10 000 controls frequency matched to cases by age, sex, and calendar year. Main Outcome Measures: Incidence rate of psoriasis and estimates of the odds ratio (OR) and 95% confidence interval (0) for psoriasis as associated with selected risk factors. Results: The incidence rate of psoriasis was 14 per 10 000 person-years. Patients with antecedents of skin disorders and skin infection within the last year carried the highest risk of developing psoriasis (OR, 3.6 [95% Cl, 3.2-4.1], and OR, 2.1. [95% CI, 1.8-2.4], respectively). Also, smoking was found to be an independent risk factors for psoriasis (OR, 1.4 [95% CI, 1.3-1.6]). We did not find an association between risk of psoriasis and antecedents of stress, diabetes, hypertension, hyperlipidemia, cardiovascular disease, or rheumatoid arthritis. Conclusions: The incidence rate in our study was higher than those published in other studies, probably owing to our case definition that considered cases recorded by the GPs independently of a specialist confirmation. Our results confirm the association between psoriasis, skin disorders, and smoking.
引用
收藏
页码:1559 / 1565
页数:7
相关论文
共 44 条
[1]  
Barisic-Drusko V, 1989, Acta Derm Venereol Suppl (Stockh), V146, P178
[2]  
Basarab T, 1996, BRIT J DERMATOL, V135, P70
[3]   INCIDENCE OF PSORIASIS IN ROCHESTER, MN, 1980-1983 [J].
BELL, LM ;
SEDLACK, R ;
BEARD, CM ;
PERRY, HO ;
MICHET, CJ ;
KURLAND, LT .
ARCHIVES OF DERMATOLOGY, 1991, 127 (08) :1184-1187
[4]  
BRAATHEN LR, 1989, ACTA DERM-VENEREOL, P9
[5]  
BRAATHEN LR, 1989, ACTA DERM-VENEREOL, P5
[6]  
BRANDRUP F, 1981, ACTA DERM-VENEREOL, V61, P344
[7]  
BRANDRUP F, 1982, ACTA DERM-VENEREOL, V62, P229
[8]   Drug exposure and psoriasis vulgaris: Case-control and case-crossover studies [J].
Cohen, AD ;
Bonneh, DY ;
Reuveni, H ;
Vardy, DA ;
Naggan, L ;
Halevy, S .
ACTA DERMATO-VENEREOLOGICA, 2005, 85 (04) :299-303
[9]  
Cohen AD, 2001, ACTA DERM-VENEREOL, V81, P347
[10]   Drug-induced psoriasis: An evidence-based overview and the introduction of psoriatic drug eruption probability score [J].
Dika, E ;
Varotti, C ;
Bardazzi, F ;
Maibach, HI .
CUTANEOUS AND OCULAR TOXICOLOGY, 2006, 25 (01) :1-11